Avian influenza in cats is a severe and frequently fatal viral infection caused by highly pathogenic avian influenza (HPAI) virus, most commonly the H5N1 subtype of influenza A. Once thought to be resistant to influenza viruses, cats have been conclusively shown to be highly susceptible to H5N1 infection, with domestic cats, feral cats, and large wild felids all capable of contracting and dying from this disease. The recognition of feline susceptibility to avian influenza fundamentally changed veterinary understanding of influenza host ranges and raised significant concerns about the potential role of cats in the broader epidemiology of pandemic influenza viruses. Avian influenza in cats carries a mortality rate estimated at up to seventy percent, making it one of the deadliest infectious diseases currently threatening feline populations.
The history of recognized avian influenza infection in cats stretches back over two decades, beginning with cases identified in Asia during the mid-2000s when H5N1 was circulating widely in poultry populations. The first documented cases of fatal H5N1 infection in domestic cats in Europe occurred during an outbreak on the German island of Ruegen in February 2006, where free-roaming cats were found dead harboring the virus. Since the emergence and global spread of the HPAI H5N1 clade 2.3.4.4b beginning around 2020, feline infections have increased substantially in frequency and geographic distribution. The United States has confirmed well over one hundred cases in domestic cats since late 2022, spanning states from California to New Jersey and affecting barn cats, feral cats, strictly indoor pet cats, and captive big cats in zoological facilities.
The pathogenesis of avian influenza in cats is notable for the systemic nature of the infection, which distinguishes it from the primarily respiratory illness seen with most mammalian influenza infections. The H5N1 virus demonstrates a remarkably broad cellular tropism in feline tissues, infecting epithelial cells, parenchymal cells, neural tissue, mesenchymal cells, and vascular endothelium. This promiscuous tissue targeting results in widespread necrosis, inflammation, and hemorrhage across multiple organ systems, with the lungs, brain, and liver most severely affected. The systemic dissemination of virus explains the multiorgan clinical syndrome and the extremely high fatality rate observed in naturally infected cats.
The significance of avian influenza in cats extends beyond feline health into the realm of public health and pandemic preparedness. Cats live in close proximity to humans and often serve as bridges between wildlife, agricultural animals, and human households. Infected cats shed virus in saliva, nasal secretions, feces, and urine, creating potential exposure risks for human caretakers and other animals in the household. The possibility that cats could serve as mixing vessels for reassortment between avian and mammalian influenza strains has been raised by experts, though no such reassortment has been documented to date. These concerns have prompted growing calls for enhanced surveillance of domestic cats and stricter biosecurity measures in settings where cats may contact infected birds or livestock.
